Literature DB >> 25623047

Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement.

Gary S Collins1, Johannes B Reitsma, Douglas G Altman, Karel G M Moons.   

Abstract

BACKGROUND: Prediction models are developed to aid healthcare providers in estimating the probability or risk that a specific disease or condition is present (diagnostic models) or that a specific event will occur in the future (prognostic models), to inform their decision-making. However, the overwhelming evidence shows that the quality of reporting of prediction model studies is poor. Only with full and clear reporting of information on all aspects of a prediction model can risk of bias and potential usefulness of prediction models be adequately assessed.
MATERIALS AND METHODS: The Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) initiative developed a set of recommendations for the reporting of studies developing, validating or updating a prediction model, whether for diagnostic or prognostic purposes. This article describes how the TRIPOD Statement was developed. An extensive list of items based on a review of the literature was created, which was reduced after a Web-based survey and revised during a 3-day meeting in June 2011 with methodologists, healthcare professionals and journal editors. The list was refined during several meetings of the steering group and in e-mail discussions with the wider group of TRIPOD contributors.
RESULTS: The resulting TRIPOD Statement is a checklist of 22 items, deemed essential for transparent reporting of a prediction model study. The TRIPOD Statement aims to improve the transparency of the reporting of a prediction model study regardless of the study methods used. The TRIPOD Statement is best used in conjunction with the TRIPOD explanation and elaboration document.
CONCLUSIONS: To aid the editorial process and readers of prediction model studies, it is recommended that authors include a completed checklist in their submission (also available at www.tripod-statement.org).
© 2015 Stichting European Society for Clinical Investigation Journal Foundation.

Keywords:  Diagnostic; model development; model validation; predictions models; prognostic; reporting

Mesh:

Year:  2015        PMID: 25623047     DOI: 10.1111/eci.12376

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  13 in total

1.  External validation of a combined PET and MRI radiomics model for prediction of recurrence in cervical cancer patients treated with chemoradiotherapy.

Authors:  François Lucia; Dimitris Visvikis; Martin Vallières; Marie-Charlotte Desseroit; Omar Miranda; Philippe Robin; Pietro Andrea Bonaffini; Joanne Alfieri; Ingrid Masson; Augustin Mervoyer; Caroline Reinhold; Olivier Pradier; Mathieu Hatt; Ulrike Schick
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-12-07       Impact factor: 9.236

2.  Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy.

Authors:  François Lucia; Dimitris Visvikis; Marie-Charlotte Desseroit; Omar Miranda; Jean-Pierre Malhaire; Philippe Robin; Olivier Pradier; Mathieu Hatt; Ulrike Schick
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-09       Impact factor: 9.236

3.  Predictive Modeling of Survival and Toxicity in Patients With Hepatocellular Carcinoma After Radiotherapy.

Authors:  Ibrahim Chamseddine; Yejin Kim; Brian De; Issam El Naqa; Dan G Duda; John Wolfgang; Jennifer Pursley; Harald Paganetti; Jennifer Wo; Theodore Hong; Eugene J Koay; Clemens Grassberger
Journal:  JCO Clin Cancer Inform       Date:  2022-02

4.  Identifying Novel Clusters of Patients With Prolonged Mechanical Ventilation Using Trajectories of Rapid Shallow Breathing Index.

Authors:  Tsung-Ming Yang; Lin Chen; Chieh-Mo Lin; Hui-Ling Lin; Tien-Pei Fang; Huiqing Ge; Huabo Cai; Yucai Hong; Zhongheng Zhang
Journal:  Front Med (Lausanne)       Date:  2022-07-04

5.  Systematic review of predictive risk models for adverse drug events in hospitalized patients.

Authors:  Nazanin Falconer; Michael Barras; Neil Cottrell
Journal:  Br J Clin Pharmacol       Date:  2018-02-22       Impact factor: 4.335

Review 6.  A Position Statement on the Utility of Interval Imaging in Standard of Care Brain Tumour Management: Defining the Evidence Gap and Opportunities for Future Research.

Authors:  Thomas C Booth; Gerard Thompson; Helen Bulbeck; Florien Boele; Craig Buckley; Jorge Cardoso; Liane Dos Santos Canas; David Jenkinson; Keyoumars Ashkan; Jack Kreindler; Nicky Huskens; Aysha Luis; Catherine McBain; Samantha J Mills; Marc Modat; Nick Morley; Caroline Murphy; Sebastian Ourselin; Mark Pennington; James Powell; David Summers; Adam D Waldman; Colin Watts; Matthew Williams; Robin Grant; Michael D Jenkinson
Journal:  Front Oncol       Date:  2021-02-09       Impact factor: 6.244

7.  Machine Learning Prediction Models for Gestational Diabetes Mellitus: Meta-analysis.

Authors:  Zheqing Zhang; Luqian Yang; Wentao Han; Yaoyu Wu; Linhui Zhang; Chun Gao; Kui Jiang; Yun Liu; Huiqun Wu
Journal:  J Med Internet Res       Date:  2022-03-16       Impact factor: 7.076

8.  Validation of a clinical scoring system for bovine respiratory disease complex diagnosis in preweaned dairy calves using a Bayesian framework.

Authors:  S Buczinski; G Fecteau; J Dubuc; D Francoz
Journal:  Prev Vet Med       Date:  2018-05-04       Impact factor: 2.670

9.  Development and validation of a 2-year new-onset stroke risk prediction model for people over age 45 in China.

Authors:  Qiang Yao; Jing Zhang; Ke Yan; Qianwen Zheng; Yawen Li; Lu Zhang; Chenyao Wu; Yanling Yang; Muke Zhou; Cairong Zhu
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

10.  [18F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation.

Authors:  Marta Ferreira; Pierre Lovinfosse; Johanne Hermesse; Marjolein Decuypere; Caroline Rousseau; François Lucia; Ulrike Schick; Caroline Reinhold; Philippe Robin; Mathieu Hatt; Dimitris Visvikis; Claire Bernard; Ralph T H Leijenaar; Frédéric Kridelka; Philippe Lambin; Patrick E Meyer; Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-26       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.